You are here

Amgen

Novartis copy of Amgen biotech drug shows similar efficacy-study

Yahoo/Reuters

Mon, 12/8/14 - 08:24 am

Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease

Yahoo/PR Newswire

Sun, 12/7/14 - 09:55 am

acute lymphoblastic leukemia

Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma

Yahoo/PR Newswire

Sat, 12/6/14 - 11:18 am

ONYX Pharmaceuticals

Multiple Myeloma

Sandoz loses bid to shield psoriasis drug

Yahoo/Reuters

Fri, 12/5/14 - 03:18 pm

Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning

Yahoo/Zacks.com

Fri, 12/5/14 - 08:49 am

acute lymphoblastic leukemia

FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia

Yahoo/AP

Wed, 12/3/14 - 09:18 pm

B-cell acute lymphoblastic leukemia

Meet 5 Top Drug Stocks That Are Bolting Past Market

Investors.com

Tue, 12/2/14 - 08:42 am

Amag Pharmaceuticals

Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown

Fierce Biotech

Wed, 11/26/14 - 11:38 am

Amgen scraps trials of drug for advanced stomach cancer

Yahoo/Reuters

Mon, 11/24/14 - 10:15 am

US biotech giant Amgen opens $200m plant in Tuas

Asia One, Singapore

Sun, 11/23/14 - 10:21 am

Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen

Barron's

Mon, 11/17/14 - 04:03 pm

Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win

Reuters

Thu, 11/13/14 - 11:29 am

Amgen psoriasis drug tops J&J's Stelara in Phase III study

Yahoo/Reuters

Wed, 11/12/14 - 08:32 am

FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab

Yahoo

Mon, 11/10/14 - 11:05 am

How Amgen Makes Billions On Just A Few Drugs

Investopedia.com

Wed, 11/5/14 - 11:11 pm

Amgen ovarian cancer drug fails to improve overall survival

Reuters

Tue, 11/4/14 - 10:30 am

Amgen and Sandoz Square Off Over a Biosimilar Application

WSJ Pharmalot

Mon, 11/3/14 - 11:45 am

Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft

FDA Law Blog

Thu, 10/30/14 - 05:43 pm

[video]Amgen CEO: We're not splitting up

CNBC

Tue, 10/28/14 - 11:35 am

Amgen adds up to 1,100 new job cuts to its global restructuring plan

Fierce Biotech

Tue, 10/28/14 - 10:35 am

Pages